UK-based IPS Pharma has signed a £7M+ import agreement with New Zealand medical cannabis producer Puro—now the largest certified organic cannabis supply deal of its kind in the world.
The agreement, signed at the New Zealand High Commission in London, marks a major step forward in patient access across the UK and Europe, where demand for high-quality medical cannabis continues to grow.
“This partnership means UK and European patients will now have access to a truly premium product—organically grown, live dried, and processed to pharmaceutical standards,” says Ian McFarlane, Director of Strategic Partnerships at IPS Pharma.
Puro’s cannabis is cultivated in Marlborough, New Zealand, using techniques developed specifically for its unique climate and growing conditions. As one of the world’s few certified organic producers, Puro applies a seven-stage live drying process designed to preserve the full cannabinoid and terpene profile of each plant.
“Patients will benefit from smoother flavours, stronger terpene profiles, and medicine that maintains its potency longer. This approach offers a clear therapeutic advantage over traditional drying methods,” says McFarlane.
The agreement also responds to ongoing shifts in medical cannabis prescribing—particularly the need for better formulation consistency, cleaner growing methods, and traceable supply chains.
“Our focus has always been on quality, reliability and compliance. What Puro is offering aligns perfectly with those values. This isn’t just about access—it’s about improving what patients are actually getting,” McFarlane added.
The product will be imported and distributed through IPS Pharma’s UK and European network, supported by MHRA-compliant manufacturing, full quality assurance, and global logistics.
Recent reforms to New Zealand’s medicinal cannabis export laws, which lowered compliance barriers for certified producers, played a key role in enabling this historic agreement.
About IPS Pharma
IPS Pharma is an independent international pharmaceutical services company based in Surrey, UK. With expertise in unlicensed medicines, clinical trials, and special obtains, IPS delivers over 20,000 formulations globally. As an MHRA-licensed manufacturer and member of the APSM, IPS provides high-quality, compliant access to medicines that support unmet patient needs.
IPS Pharma is an independent international pharmaceutical services company based in Surrey, UK. With expertise in unlicensed medicines, clinical trials, and special obtains, IPS delivers over 20,000 formulations globally. As an MHRA-licensed manufacturer and member of the APSM, IPS provides high-quality, compliant access to medicines that support unmet patient needs.
About Puro
Puro is New Zealand’s leading certified organic medical cannabis grower, cultivating premium cannabis on coastal farms in Marlborough. Backed by government investment and focused on sustainable production, Puro supplies pharmaceutical companies globally with consistently high-quality, organically certified cannabis products.
Puro is New Zealand’s leading certified organic medical cannabis grower, cultivating premium cannabis on coastal farms in Marlborough. Backed by government investment and focused on sustainable production, Puro supplies pharmaceutical companies globally with consistently high-quality, organically certified cannabis products.
